BioDelivery Sciences (BDSI) Reports In-Line Q2 EPS

August 9, 2016 6:56 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

BioDelivery Sciences (NASDAQ: BDSI) reported Q2 EPS of ($0.31), in-line with the analyst estimate of ($0.31). Revenue for the quarter came in at $5 million versus the consensus estimate of $3.35 million.

For earnings history and earnings-related data on BioDelivery Sciences (BDSI) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment